Yu B - Search Results

1

Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial.

Yue D, Wang W, Liu H, Chen Q, Chen C, Liu L, Zhang P, Zhao G, Yang F, Han G, Cheng Y, Yu B, Yang Y, Chen H, Jiang J, Tan L, Xu S, Mao N, Hu J, Zhang L, Yao B, Wang S, Wang RH, Zheng W, Wang C; RATIONALE-315 investigators. Yue D, et al. Among authors: yu b. Lancet Respir Med. 2024 Nov 21:S2213-2600(24)00269-8. doi: 10.1016/S2213-2600(24)00269-8. Online ahead of print. Lancet Respir Med. 2024. PMID: 39581197

2

Impact of treatment modality on long-term survival of stage IA small-cell lung cancer patients: a cohort study of the U.S. SEER database.

Lin SF, Zheng YZ, Li XQ, Xu HP, Wang JJ, Wang W, Huang QY, Wu D, Zhong CX, Fu SS, Yuan LX, Wang SC, Luo RX, Zhai WY, Yu BT, Zhu KS. Lin SF, et al. Ann Transl Med. 2020 Oct;8(20):1292. doi: 10.21037/atm-20-5525. Ann Transl Med. 2020. PMID: 33209872 Free PMC article.

3

Feasibility of double sleeve lobectomy after neoadjuvant chemotherapy in patients with non-small-cell lung cancer.

Bao Y, Jiang C, Wan Z, Wang Y, Zhong Y, Deng J, She Y, Jiang L, Hu X, Zhu Y, Yu B, Chen C. Bao Y, et al. Among authors: yu b. Interact Cardiovasc Thorac Surg. 2022 Jul 9;35(2):ivac103. doi: 10.1093/icvts/ivac103. Interact Cardiovasc Thorac Surg. 2022. PMID: 35416960 Free PMC article.

4

Expert consensus on indocyanine green fluorescence imaging for thoracoscopic lung resection (The Version 2022).

Cui F, Liu J, Du M, Fan J, Fu J, Geng Q, He M, Hu J, Li B, Li S, Li X, Liao YD, Lin L, Liu F, Liu J, Lv J, Pu Q, Tan L, Tian H, Wang M, Wang T, Wei L, Xu C, Xu S, Xu S, Yang H, Yu BT, Yu G, Yu Z, Lee CY, Pompeo E, Azari F, Igai H, Kim HK, Andolfi M, Hamaji M, Bassi M, Karenovics W, Yutaka Y, Shimada Y, Sakao Y, Sihoe ADL, Zhang Y, Zhang Z, Zhao J, Zhong W, Zhu Y, He J. Cui F, et al. Among authors: yu bt, yu g, yu z. Transl Lung Cancer Res. 2022 Nov;11(11):2318-2331. doi: 10.21037/tlcr-22-810. Transl Lung Cancer Res. 2022. PMID: 36519017 Free PMC article. Review.

5

Development of nomogram based on immune-related gene FGFR4 for advanced non-small cell lung cancer patients with sensitivity to immune checkpoint inhibitors.

Wang L, Ren Z, Yu B, Tang J. Wang L, et al. Among authors: yu b. J Transl Med. 2021 Jan 6;19(1):22. doi: 10.1186/s12967-020-02679-0. J Transl Med. 2021. PMID: 33407583 Free PMC article.

6

Deep learning for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer: A multicentre study.

She Y, He B, Wang F, Zhong Y, Wang T, Liu Z, Yang M, Yu B, Deng J, Sun X, Wu C, Hou L, Zhu Y, Yang Y, Hu H, Dong D, Chen C, Tian J. She Y, et al. Among authors: yu b. EBioMedicine. 2022 Dec;86:104364. doi: 10.1016/j.ebiom.2022.104364. Epub 2022 Nov 14. EBioMedicine. 2022. PMID: 36395737 Free PMC article.

7

Effect of pleural invasion on survival of patients with small cell lung cancer: Propensity score analysis and nomogram establishment based on the SEER database.

Yang J, Yin H, Liu M, Zou G, Yu B. Yang J, et al. Among authors: yu b. Front Surg. 2023 Feb 23;10:1108732. doi: 10.3389/fsurg.2023.1108732. eCollection 2023. Front Surg. 2023. PMID: 36911624 Free PMC article.

8

Two-year outcomes of clinical N2-3 esophageal squamous cell carcinoma after neoadjuvant chemotherapy and immunotherapy from the phase 2 NICE study.

Yang Y, Liu J, Liu Z, Zhu L, Chen H, Yu B, Zhang R, Shao J, Zhang M, Li C, Li Z. Yang Y, et al. Among authors: yu b. J Thorac Cardiovasc Surg. 2024 Mar;167(3):838-847.e1. doi: 10.1016/j.jtcvs.2023.08.056. Epub 2023 Sep 9. J Thorac Cardiovasc Surg. 2024. PMID: 37696429 Clinical Trial.

9

GRHL2 suppresses tumor metastasis via regulation of transcriptional activity of RhoG in non-small cell lung cancer.

Pan X, Zhang R, Xie C, Gan M, Yao S, Yao Y, Jin J, Han T, Huang Y, Gong Y, Wang J, Yu B. Pan X, et al. Among authors: yu b. Am J Transl Res. 2017 Sep 15;9(9):4217-4226. eCollection 2017. Am J Transl Res. 2017. PMID: 28979695 Free PMC article.

10

The Anti-Non-Small Cell Lung Cancer Cell Activity by a mTOR Kinase Inhibitor PQR620.

Zha JH, Xia YC, Ye CL, Hu Z, Zhang Q, Xiao H, Yu BT, Xu WH, Xu GQ. Zha JH, et al. Front Oncol. 2021 Jun 10;11:669518. doi: 10.3389/fonc.2021.669518. eCollection 2021. Front Oncol. 2021. PMID: 34178653 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,422 results

Search Page

Filters